Treating metastatic melanoma: further considerations.
Legha
Sewa S
SS
Baylor College of Medicine, Houston, Texas, USA.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001921:Brain / Q000473:pathology; D001932:Brain Neoplasms / Q000175:diagnosis / Q000556:secondary; D006801:Humans; D007167:Immunotherapy; D007376:Interleukin-2 / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging; D008545:Melanoma / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology
D000970:Antineoplastic Agents; D007376:Interleukin-2